Core and Group Health

Officials want to know whether U.S. manufacturers can meet patients' needs, and whether the country needs new tariffs or quotes.

The executive order was praised by an unlikely source – Mark Cuban, who started Cost Plus Drugs in 2022 in an attempt to control prices through direct-to-consumer transparency.

The growing chasm in customer experience begs the question: What are the top health plans doing well that the lowest-ranked plans cannot seem to get right?

Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the market, as the drugmaker expects to submit the drug for approval for weight loss by the end of the year.

Affordable Care Act public exchange activities would have to rely on user fees and other program revenue.

Andrew Witty hopes a new executive order will lead to a review of all players in the sector.